EcoDrugPlus

60s Ribosomal Protein L18

Ensembl ID : ENSOKIG00005002294
Gene Symbol: LOC109883196
3 Cross references
375 Possible Orthologues:

60s Ribosomal Protein L18

Ensembl ID : ENSOKIG00005034725
Gene Symbol: LOC109883196
3 Cross references
374 Possible Orthologues:

60s Ribosomal Protein L19-Like

Ensembl ID : ENSOKIG00005034484
Gene Symbol: LOC109893292
3 Cross references
345 Possible Orthologues:

60s Ribosomal Protein L19-Like

Ensembl ID : ENSOKIG00005021051
Gene Symbol: LOC109893292
3 Cross references
345 Possible Orthologues:

60s Ribosomal Protein L21

Ensembl ID : ENSOKIG00005008531
Gene Symbol: LOC109899252
3 Cross references
778 Possible Orthologues:

60s Ribosomal Protein L22

Ensembl ID : ENSOKIG00005038176
Gene Symbol: LOC109896584
2 Cross references
197 Possible Orthologues:

60s Ribosomal Protein L22

Ensembl ID : ENSOKIG00005014976
Gene Symbol: LOC109907862
3 Cross references
206 Possible Orthologues:

60s Ribosomal Protein L22

Ensembl ID : ENSOKIG00005043585
Gene Symbol: LOC109869362
2 Cross references
203 Possible Orthologues:

60s Ribosomal Protein L23

Ensembl ID : ENSOKIG00005003270
Gene Symbol: LOC109898543
3 Cross references
226 Possible Orthologues:

60s Ribosomal Protein L24

Ensembl ID : ENSOKIG00005001647
Gene Symbol: LOC109870579
3 Cross references
311 Possible Orthologues:

60s Ribosomal Protein L24

Ensembl ID : ENSOKIG00005008807
Gene Symbol: LOC109870579
2 Cross references
313 Possible Orthologues:

60s Ribosomal Protein L26

Ensembl ID : ENSOKIG00005041732
Gene Symbol: LOC109878609
3 Cross references
472 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).